Annual report [Section 13 and 15(d), not S-K Item 405]

Significant Accounting Policies - Narratives (Details)

v3.26.1
Significant Accounting Policies - Narratives (Details)
$ in Thousands
 12 Months Ended
Apr. 11, 2025
Dec. 31, 2025
USD ($)
customer
Dec. 31, 2024
USD ($)
customer
Concentration Risk      
Number of customers (customer) | customer     4
TOTAL OPERATING REVENUE   $ 1,459,080 $ 1,500,455
Contract with Customer, Liability, Revenue Recognized     12,700
Term of contract   1 month  
Accrued expenses and other current liabilities   $ 42,391 29,416
Capitated Revenue [Member]      
Concentration Risk      
TOTAL OPERATING REVENUE   $ 1,428,979 $ 1,483,602
Term for reconciliation and distribution of the reserve following end of each quarter   120 days  
Term for reconciliation and distribution of the reserve following each year-end   21 months  
Class A Common Stock      
Concentration Risk      
Stockholders' Equity Note, Stock Split, Conversion Ratio 0.02    
Class V Common Stock      
Concentration Risk      
Stockholders' Equity Note, Stock Split, Conversion Ratio 0.02    
Scenario, Adjustment      
Concentration Risk      
Interest Expense, Operating   $ 4,700  
Accrued expenses and other current liabilities   $ 18,300  
Four Health Plan Customer | Revenue | Customer Concentration      
Concentration Risk      
Number of customers (customer) | customer     4
Percentage of total revenue (as a percent)   75.00% 59.00%
Five Health Plan Customer [Member] | Revenue | Customer Concentration      
Concentration Risk      
Number of customers (customer) | customer   4  
PMPM | Capitated Revenue [Member]      
Concentration Risk      
TOTAL OPERATING REVENUE   $ 36,700 $ 33,500